Mm. Moxeymims et B. Noble, GLOMERULAR MACROPHAGE PHAGOCYTIC-ACTIVITY IN EXPERIMENTAL IMMUNE-COMPLEX NEPHRITIS, Kidney international, 45(5), 1994, pp. 1326-1332
In rats with the proliferative immune complex glomerulonephritis of ch
ronic serum sickness, kidney function deteriorates in three clearly di
stinguishable and discrete stages: mild, moderate and severe. The macr
ophage component of glomerular inflammation in each stage is also quan
titatively and qualitatively distinct, with abnormal phenotypic marker
s appearing in the moderate stage and increasing in the severe stage.
To determine whether there were distinct functional differences among
macrophages from the three stages, Fc gamma receptor-mediated phagocyt
ic capacity was measured. The phagocytic capacity of glomerular macrop
hages increased significantly in the moderate stage, then significantl
y decreased, as rats progressed to severe chronic serum sickness. This
decline in phagocytic function was not associated with a decrease in
the expression of Fc gamma receptors on the glomerular macrophage cell
surface. Furthermore, the phagocytic function of peritoneal macrophag
es from rats with severe chronic serum sickness was not impaired. Whet
her or not this attenuation of glomerular macrophage phagocytic capaci
ty is the cause, or result, of renal disease progression remains uncle
ar. It may indicate a potentially protective role for intraglomerular
macrophages, and can serve as an additional functional marker of disea
se progression.